Browse/search for people

Dr Kathleen Gillespie

Dr Kathleen Gillespie

Dr Kathleen Gillespie
B.Sc.(Galway), Ph.D.(Wales)

Reader in Molecular Medicine

Area of research

Genetic mechanisms underlying autoimmunity

Diabetes and Metabolism,
Second Floor, Learning and Research BS10 5NB
(See a map)

+44 (0) 117 323 5336
+44 (0) 117 41 48058

Summary

Kathleen has led Diabetes and Metabolism since November 2014, when she also became Chief Investigator of the Bart's Oxford (BOX) family study of type 1 diabetes. She is a molecular biologist interested in the mechanisms underlying autoimmunity. Her current projects include

  • an international collaborative study of why some children develop type 1 diabetes in the first few years of life while others who have the markers of ongoing islet autoimmunity are not diagnosed until adulthood
  • examining lomgitudinal data from the BOX study to predict outcomes
  • developing new biomarker assays 
  • understanding why children with Down's syndrome are at increased risk of autoimmunity 

Current funding has been provided by Diabetes UK, the Juvenile Diabetes Research Foundation International and the European Foundation for the study of diabetes.

Keywords

  • Autoimmunity Genetics HLA

Skills

  • Type 1 diabetes

Memberships

Organisations

Bristol Medical School (THS)

Other sites

Academic staff

Research groupings

Recent publications

View complete publications list in the University of Bristol publications system

Edit this profile If you are Dr Kathleen Gillespie, you can edit this page. Login required.

PDF versionDownload PDF